Workflow
智飞生物(300122) - 2014 Q4 - 年度业绩预告
ZHIFEI-BIOLZHIFEI-BIOL(SZ:300122)2015-01-21 11:07

Financial Performance - The company expects a net profit attributable to shareholders to be between 130.35 million and 169.45 million CNY, representing a year-on-year growth of 5% to 30%[3] - The net profit growth is expected to be 5% to 30% after excluding non-recurring gains and losses, which have a minimal impact on overall performance[7] - The performance forecast is based on preliminary assessments by the company's finance department and carries a degree of uncertainty[8] Sales and Marketing - The increase in sales expenses is attributed to intensified marketing efforts and the promotion of important new products prior to their launch[5] Product Management - The company reported a decrease in product expiration losses compared to the previous year[6]